SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-09-001497
Filing Date
2009-10-27
Accepted
2009-10-27 17:08:34
Documents
1
Group Members
BAM CAPITAL, LLCBAM MANAGEMENT, LLCBAM OFFSHORE MANAGEMENT, LLCBAM TOTAL RETURN MASTER FUND, LTD.HAL MINTZROSS BERMAN

Document Format Files

Seq Description Document Type Size
1 amag_sch13g.htm SC 13G 224390
  Complete submission text file 0000929638-09-001497.txt   226593
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02140
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Subject) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-38286 | Film No.: 091139828
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 44 WALL STREET SUITE 1603 NEW YORK NY 10005
Business Address 44 WALL STREET SUITE 1603 NEW YORK NY 10005 646-307-4503
BAM Opportunity Fund, L.P. (Filed by) CIK: 0001433768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G